Drug Delivery

  • Print
   
   

Drug Delivery 

Researchers within the CBTRC are investigating a number of molecular research avenues that could lead to new targets for brain tumour treatments. They are also working to optimise drug delivery to tumour sites within the brain, bypassing the body’s protective membrane – the blood brain barrier. CBTRC researchers are also involved in national and international clinical trials programmes that are testing new and modified treatment approaches.

Who to contact

Ruman Rahman

Selected publications

BNOS 2017 Meeting June 21-23, 2017 John McIntyre Conference Centre, Edinburgh ​
SMITH S., GOULD, T., TYLER, B., RITCHIE, A., VEAL, G., SHAKESHEFF, K., BREM, H., GRUNDY, R., RAHMAN, R., (2018) Overall survival in an orthotopic GBM model is significantly prolonged by neurosurgical delivery of PLGA/PEG interstitial chemotherapy. Neuro-Oncology, Volume 20, Issue suppl_1, 31 January 2018, Pages i6, ​

IVANOV, D.P., PARKER, T.L., WALKER, D.A., (et al), (2015) In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment (2015) Journal of Biotechnology ​

RAHMAN, R., (2014) Biomaterial-based local drug delivery to brain tumors. Therapeutic Delivery (IF 1.4) 5(12): 1243-1245